Is β2-Microglobulin-Related Amyloidosis of Hemodialysis Patients a Multifactorial Disease? a New Pathogenetic Approach
Open Access
- 1 October 2007
- journal article
- research article
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 30 (10) , 864-878
Abstract
Purpose: β2-microglobulin amyloidosis (Aβ2M) is one of the main long-term complications of dialysis treatment. The incidence and the onset of Aβ2M has been related to membrane composition and/or dialysis technique, with non-homogeneous results. This study was carried out to detect: i) the incidence of bone cysts and CTS from Aβ2M; ii) the difference in Aβ2M onset between cellulosic and synthetic membranes; iii) other risk factors besides the membrane. Methods: 480 HD patients were selected between 1986 to 2005 and grouped according to the 4 types of membranes used (cellulose, synthetically modified cellulose, synthetic low-flux, synthetic high-flux). The patients were analyzed before and after 1995, when the reverse osmosis treatment for dialysis water was started at our center, and the incidence of Aβ2M was compared between the two periods. Routine plain radiography, computer tomography (CT) and nuclear magnetic resonance imaging (MRI) as well as electromyography were used to investigate the clinical symptoms. Results: Bone cysts occurred in 29.2% of patients before 1995 vs. 12.2% after 1995 (p2M. Conclusions: The findings that the inflammatory status as well as low albumin and the residual GFR of the uremic patient are predictive of Aβ2M lesions suggests that Aβ2M has a multifactorial origin rather than being solely a membrane- or technique-related side effect.Keywords
This publication has 66 references indexed in Scilit:
- Dialysis-related AmyloidosisSeminars in Musculoskeletal Radiology, 2001
- Effects of ultrapure dialysis fluid on nutritional status and inflammatory parametersNephrology Dialysis Transplantation, 2001
- Rebound kinetics of β2-microglobulin after hemodialysisKidney International, 1999
- Fatal cervical spondyloarthropathy in a hemodialysis patient with systemic deposition of β-microglobulin amyloidAmerican Journal of Kidney Diseases, 1999
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999
- β2-microglobulin associated amyloidosis: A vanishing complication of long-term hemodialysis?Kidney International, 1997
- Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranesKidney International, 1995
- Structure of Dialysis Membranes and Long-Term Clinical OutcomeAmerican Journal of Nephrology, 1995
- Cystic Radiolucencies of Carpal Bones, Distal Radius and Ulna as a Marker for Dialysis-Associated Amyloid OsteoarthropathyNephron, 1992
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985